文献速递泌尿生殖MRUS

MRI靶向穿刺对比标准经直肠超声引导穿刺:随机对照试验的系统评价与Meta分析

MRI-targeted biopsy versus standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis of randomized controlled trials.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

该系统评价与Meta分析纳入8项随机对照试验共2593例疑似前列腺癌患者,比较MRI靶向穿刺与经直肠超声引导穿刺的检出率。两组总体前列腺癌、临床显著前列腺癌及临床不显著前列腺癌检出率无显著差异;在初次穿刺患者中,MRI靶向穿刺的总体前列腺癌检出率显著更高。

要点

  • 在初次穿刺患者中,MRI靶向穿刺的总体前列腺癌检出率显著高于经直肠超声引导穿刺(RR=1.40,95%CI 1.01-1.94,P=0.045)。
  • 全体人群中,MRI靶向穿刺与经直肠超声引导穿刺的总体前列腺癌检出率无显著差异(RR=1.30,95%CI 0.98-1.72,P=0.067)。
  • 既往穿刺阴性患者中,两种穿刺方式的总体及临床显著前列腺癌检出率均无显著差异。

诊断标准与关键数值

  • 全体人群中,MRI靶向穿刺对比经直肠超声引导穿刺的总体前列腺癌检出率RR=1.30(95%CI 0.98-1.72,P=0.067)。
  • 全体人群中,临床显著前列腺癌检出率RR=1.35(95%CI 0.98-1.86,P=0.065)。
  • 全体人群中,临床不显著前列腺癌检出率RR=0.76(95%CI 0.40-1.46,P=0.416)。
  • 初次穿刺患者中,MRI靶向穿刺的总体前列腺癌检出率RR=1.40(95%CI 1.01-1.94,P=0.045)。

临床应用与阅片要点

  • 作者认为,对于疑似前列腺癌患者,MRI靶向穿刺相比经直肠超声引导穿刺可能有助于提高总体及临床显著前列腺癌的检出。
  • 作者指出,在初次穿刺患者中,MRI靶向穿刺的总体前列腺癌检出率显著更高,临床显著前列腺癌检出率可能更高。
  • 作者指出,对于既往穿刺阴性患者,两种穿刺方式在总体及临床显著前列腺癌检出率上未检测到显著差异。

局限性

  • 原文结论指出,仍需更多大型多中心随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: For men with a suspicion of prostate cancer (PCa), the transrectal ultrasound-guided biopsy (TRUS-Bx) was recommended. Multi-parametric magnetic resonance imaging (mp-MRI) could be more useful to more accurately selected patients who are with a clinical suspicion of PCa and eligible for biopsy, and avoid a biopsy if the result was negative. In the present study, we compared the MRI-targeted biopsy (MRI-TBx) with TRUS-Bx.

METHODS: We searched the following online database: PubMed, Embase, and Cochrane Library, and the search was updated to March 2019.

RESULTS: Finally, a total of 8 randomized controlled trials (RCTs) comprising 2593 patients were enrolled in the final analysis. MRI-TBx and TRUS-Bx did not significantly differ in overall PCa (RR = 1.30; 95% CI 0.98-1.72; P = 0.067), clinically significant PCa (RR = 1.35; 95% CI 0.98-1.86; P = 0.065), and clinically insignificant PCa (RR = 0.76; 95% CI 0.40-1.46; P = 0.416). While in patients with initial biopsy, MRI-TBx had a significantly higher detection rate of overall PCa (RR = 1.40; 95% CI 1.01-1.94; P = 0.045).

CONCLUSION: In the present study, we found that MRI-TBx potentially benefits the detection of overall and clinically significant PCa compared with TRUS-Bx in patients with a suspicion of PCa. Furthermore, in patients with initial biopsy, MRI-TBx had a significantly higher detection rate of overall PCa and a potentially higher detection rate of clinically significant PCa. While for patients with prior negative biopsy, we did not detect significant differences in overall and clinically significant PCa between two groups. More large and multicenter RCTs are further required.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Hu X, Yang ZQ, Shao YX, et al. MRI-targeted biopsy versus standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis of randomized controlled trials. Abdom Radiol (NY). 2020. PMID: 31897680. doi:10.1007/s00261-019-02370-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。